IS2744B - Tæki til þess að öngla, ásamt möguleika til þess að beita línu - Google Patents

Tæki til þess að öngla, ásamt möguleika til þess að beita línu

Info

Publication number
IS2744B
IS2744B IS8304A IS8304A IS2744B IS 2744 B IS2744 B IS 2744B IS 8304 A IS8304 A IS 8304A IS 8304 A IS8304 A IS 8304A IS 2744 B IS2744 B IS 2744B
Authority
IS
Iceland
Prior art keywords
angling
ability
apply
devices
line
Prior art date
Application number
IS8304A
Other languages
English (en)
Other versions
IS8304A (is
Inventor
Markus Bergauer
Barbara Bertani
Matteo Biagetti
Steven Mark Bromidge
Alessandro Falchi
Colin Philip Leslie
Giancarlo Merlo
Domenica Antonia Pizzi
Marilisa Rinaldi
Luigi Piero Stasi
Jessica Tibasco
Antonio Kuok Keong Vong
Simon Edward Ward
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IS8304A publication Critical patent/IS8304A/is
Publication of IS2744B publication Critical patent/IS2744B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS8304A 2003-07-18 2006-02-15 Tæki til þess að öngla, ásamt möguleika til þess að beita línu IS2744B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0316915.8A GB0316915D0 (en) 2003-07-18 2003-07-18 Compounds
PCT/EP2004/008000 WO2005014552A1 (en) 2003-07-18 2004-07-15 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors

Publications (2)

Publication Number Publication Date
IS8304A IS8304A (is) 2006-02-15
IS2744B true IS2744B (is) 2011-08-15

Family

ID=27764115

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8304A IS2744B (is) 2003-07-18 2006-02-15 Tæki til þess að öngla, ásamt möguleika til þess að beita línu

Country Status (29)

Country Link
US (5) US7279481B2 (is)
EP (3) EP2145622A1 (is)
JP (1) JP2006528146A (is)
KR (1) KR20060041242A (is)
CN (1) CN100441571C (is)
AR (1) AR046394A1 (is)
AT (2) ATE448205T1 (is)
AU (1) AU2004263268B2 (is)
BR (1) BRPI0412695A (is)
CA (1) CA2532452A1 (is)
CY (1) CY1107974T1 (is)
DE (2) DE602004012564T2 (is)
DK (1) DK1646613T3 (is)
ES (2) ES2302543T3 (is)
GB (1) GB0316915D0 (is)
HK (1) HK1089438A1 (is)
HR (1) HRP20080226T3 (is)
IL (1) IL173036A0 (is)
IS (1) IS2744B (is)
MA (1) MA27926A1 (is)
MX (1) MXPA06000716A (is)
NO (1) NO20060774L (is)
NZ (1) NZ544586A (is)
PL (1) PL1646613T3 (is)
PT (1) PT1646613E (is)
RU (1) RU2402533C2 (is)
SI (1) SI1646613T1 (is)
TW (1) TW200521115A (is)
WO (1) WO2005014552A1 (is)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
EP1765327B1 (en) * 2004-06-17 2014-08-13 Cytokinetics, Inc. Compounds, compositions and methods
KR100817538B1 (ko) * 2006-07-05 2008-03-27 한국화학연구원 신규 치환된―1h―퀴나졸린―2,4―디온 유도체, 이의제조방법 및 이를 함유하는 약학적 조성물
AU2007333656A1 (en) * 2006-12-19 2008-06-26 University Of Virginia Patent Foundation Combined effects of topiramate and ondansetron on alcohol consumption
US20100076006A1 (en) * 2007-01-31 2010-03-25 University Of Virginia Patent Foundation Topiramate Plus Naltrexone for the Treatment of Addictive Disorders
DE602007012683D1 (de) 2007-07-19 2011-04-07 Esteve Labor Dr Substituierte Tetrahydro-Chinolinsulfonamidverbindungen, ihre Herstellung und ihre Verwendung als Medikamente
US20110065628A1 (en) * 2007-08-27 2011-03-17 University Of Virginia Patent Foundation Medication Combinations for the Treatment of Alcoholism and Drug Addiction
EA019200B1 (ru) * 2008-02-28 2014-01-30 Юниверсити Оф Вирджиния Пэтент Фаундейшн Способ прогнозирования предрасположенности к развитию аддиктивного заболевания или расстройства (варианты)
CA2722326A1 (en) 2008-04-24 2009-10-29 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
EP2298199B1 (en) * 2008-05-06 2012-05-23 Biedermann Technologies GmbH & Co. KG Rod-shaped implant, in particular for the dynamic stabilization of the spine
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron
CN101671336B (zh) 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
EP2308850A1 (en) * 2009-10-06 2011-04-13 Laboratorios Del. Dr. Esteve, S.A. Heterocycyl-substituted-alkylamino phenyl derivatives, their preparation and use as medicaments
NZ605709A (en) 2010-07-02 2014-08-29 Univ Virginia Patent Found Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
US9278931B2 (en) 2011-08-09 2016-03-08 Takeda Pharmaceutical Company Limited Cyclopropaneamine compound
WO2013036721A1 (en) 2011-09-09 2013-03-14 University Of Virginia Patent Foundation Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2013169964A1 (en) * 2012-05-09 2013-11-14 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN103508927A (zh) * 2012-06-25 2014-01-15 天津药物研究院 一种2-甲磺酰氨基二苯醚的制备方法
WO2014058071A1 (ja) 2012-10-12 2014-04-17 武田薬品工業株式会社 シクロプロパンアミン化合物およびその用途
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
DK3072884T3 (da) 2013-11-20 2020-03-09 Sanwa Kagaku Kenkyusho Co 3-azabicyclo[3.1.0]hexanderivat og anvendelse deraf til medicinske formål
UA122205C2 (uk) 2014-04-11 2020-10-12 Такеда Фармасьютікал Компані Лімітед Сполука циклопропанаміну та її застосування
FR3028527A1 (fr) 2014-11-13 2016-05-20 Pivert Identification de facteurs de transcription de yarrowia lipolytica
WO2016075314A1 (fr) 2014-11-13 2016-05-19 Institut National De La Recherche Agronomique Identification de facteurs de transcription de yarrowia lipolytica affectant la production de proteines
JP6427278B2 (ja) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited pirinポリペプチド及び免疫モジュレーション
SI3065748T1 (en) 2014-12-23 2018-05-31 4D Pharma Research Limited Severe bacteroid tethethioomycron and its use in reducing inflammation
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN114984057A (zh) 2015-06-15 2022-09-02 4D制药研究有限公司 包含细菌菌株的组合物
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SI3360559T1 (sl) 2015-06-15 2020-02-28 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
EP3209310B1 (en) 2015-11-20 2018-01-31 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
NZ745678A (en) 2016-03-04 2019-03-29 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (zh) 2016-07-13 2018-06-16 英商4D製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
AU2018272291A1 (en) 2017-05-22 2020-01-16 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
ES2917415T3 (es) 2017-06-14 2022-07-08 4D Pharma Res Ltd Composiciones que comprenden una cepa bacteriana
CN111107859B (zh) 2017-06-14 2022-04-29 4D制药研究有限公司 包含细菌菌株的组合物
CN108047143A (zh) * 2017-12-18 2018-05-18 刘凤娟 一种用于治疗功能性胃肠病的5-羟色胺受体拮抗剂的合成方法
SI3814347T1 (sl) 2018-06-27 2023-07-31 Bristol-Myers Squibb Company Naftiridinonske spojine uporabne kot T celični aktivatorji
SG11202012972YA (en) 2018-06-27 2021-01-28 Bristol Myers Squibb Co Substituted naphthyridinone compounds useful as t cell activators
AR119821A1 (es) 2019-08-28 2022-01-12 Bristol Myers Squibb Co Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
AR120823A1 (es) 2019-12-23 2022-03-23 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como activadores de células t
CN118308475A (zh) * 2024-03-18 2024-07-09 安徽医科大学第一附属医院 Htr1b作为胚胎发育停滞的诊断标志物和治疗靶点方面的应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641602A (en) 1950-11-29 1953-06-09 Eastman Kodak Co 1, 8-dihydroxy-5-nitro-4-hydroxyethylphenyl aminoanthraquinone compounds
US3937708A (en) * 1971-06-07 1976-02-10 Boehringer Ingelheim Gmbh N-phenyl-imidazolidine-1-ones
US3992537A (en) * 1971-06-07 1976-11-16 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-phenyl-imidazolidine-2-one and method of use
US3975525A (en) * 1971-06-07 1976-08-17 Boehringer Ingelheim Gmbh N-[4'-Imidazolidinon-(2)-yl-phenethyl]-N'-pyridyl-piperazines and salts thereof
JPS5883677A (ja) 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
US4891275A (en) * 1982-10-29 1990-01-02 Norsk Hydro A.S. Aluminum shapes coated with brazing material and process of coating
JPS6354363A (ja) 1986-08-26 1988-03-08 Ss Pharmaceut Co Ltd キノリン誘導体
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US4933447A (en) * 1987-09-24 1990-06-12 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US4891375A (en) * 1988-01-13 1990-01-02 Pfizer Inc. Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
JP2777159B2 (ja) 1988-12-22 1998-07-16 エーザイ株式会社 環状アミン誘導体を含有する医薬
GB9300194D0 (en) 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
GB9308725D0 (en) 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives
NZ331860A (en) 1996-03-29 2000-04-28 Duphar Int Res Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors
WO1997041108A1 (en) 1996-04-30 1997-11-06 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
GB2312843A (en) 1996-05-07 1997-11-12 Merck & Co Inc Method of treating rheumatoid arthritis
WO1998025617A1 (en) 1996-12-13 1998-06-18 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
EP0900792B1 (en) 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
DE69819266T2 (de) * 1997-09-02 2004-07-29 Duphar International Research B.V. Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
JP2002508366A (ja) * 1997-12-12 2002-03-19 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー キノリンピペラジンおよびキノリンピペリジン誘導体、それらの製造方法、ならびに複合的5−ht1a、5−ht1bおよび5−ht1d受容体アンタゴニストとしてのそれらの用途
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
WO2000078716A1 (fr) 1999-06-24 2000-12-28 Toray Industries, Inc. ANTAGONISTES DU RECEPTEUR ADRENERGIQUE-α¿1B?
ES2234683T3 (es) 1999-11-05 2005-07-01 Smithkline Beecham Plc Derivados de isoquinolina y quinazolina con actividad combinada sobre los receptores 5ht1a, 5ht1b y 5ht1d.
PL366378A1 (en) 2000-10-26 2005-01-24 Smithkline Beecham P.L.C. Benzoxazinone derivatives, their preparation and use
CA2364211A1 (en) 2000-12-05 2002-06-05 Phillip Branch Chappell Combination treatment for depression, anxiety and psychosis
GB0106419D0 (en) * 2001-03-15 2001-05-02 Smithkline Beecham Plc Novel compounds
UY27304A1 (es) * 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0224084D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
CA2505397A1 (en) 2002-11-08 2004-05-21 Warner-Lambert Company Llc Phenylalkyl and pyridylalkyl piperazine derivatives
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US6759435B1 (en) * 2003-07-03 2004-07-06 A.P. Group Inc. Antidepressant drugs and methods
GB0316915D0 (en) * 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
US20050124625A1 (en) * 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
WO2005087742A1 (en) 2004-03-08 2005-09-22 Exelixis, Inc. Metabolic kinase modulators and methods of use as pesticides
US20070185149A1 (en) 2004-03-10 2007-08-09 Altana Pharma Ag Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors
PE20060653A1 (es) 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Also Published As

Publication number Publication date
WO2005014552A1 (en) 2005-02-17
CN100441571C (zh) 2008-12-10
DE602004024141D1 (de) 2009-12-24
RU2006104993A (ru) 2006-08-10
GB0316915D0 (en) 2003-08-20
DE602004012564D1 (de) 2008-04-30
US20090312546A1 (en) 2009-12-17
CA2532452A1 (en) 2005-02-17
HK1089438A1 (en) 2006-12-01
EP2145622A1 (en) 2010-01-20
PT1646613E (pt) 2008-06-19
IL173036A0 (en) 2006-06-11
EP1876174A1 (en) 2008-01-09
BRPI0412695A (pt) 2006-10-03
US7732600B2 (en) 2010-06-08
ATE389637T1 (de) 2008-04-15
CY1107974T1 (el) 2013-09-04
HRP20080226T3 (en) 2008-06-30
KR20060041242A (ko) 2006-05-11
IS8304A (is) 2006-02-15
MXPA06000716A (es) 2006-03-30
JP2006528146A (ja) 2006-12-14
US7459456B2 (en) 2008-12-02
ATE448205T1 (de) 2009-11-15
DE602004012564T2 (de) 2009-04-30
AU2004263268B2 (en) 2010-12-16
US20100204273A1 (en) 2010-08-12
US20080280919A1 (en) 2008-11-13
NO20060774L (no) 2006-04-06
AU2004263268A1 (en) 2005-02-17
DK1646613T3 (da) 2008-07-14
SI1646613T1 (sl) 2008-08-31
EP1876174B1 (en) 2009-11-11
US7279481B2 (en) 2007-10-09
CN1852896A (zh) 2006-10-25
PL1646613T3 (pl) 2008-08-29
US7592346B2 (en) 2009-09-22
NZ544586A (en) 2009-05-31
TW200521115A (en) 2005-07-01
EP1646613A1 (en) 2006-04-19
ES2302543T3 (es) 2008-07-16
US20060229312A1 (en) 2006-10-12
EP1646613B1 (en) 2008-03-19
US20070167423A1 (en) 2007-07-19
AR046394A1 (es) 2005-12-07
ES2336148T3 (es) 2010-04-08
MA27926A1 (fr) 2006-06-01
RU2402533C2 (ru) 2010-10-27

Similar Documents

Publication Publication Date Title
IS2744B (is) Tæki til þess að öngla, ásamt möguleika til þess að beita línu
ATE419769T2 (de) System mit kapsel mit dichtmitteln
IL179966A0 (en) Steerable, follow the leader device
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
DE602005010275D1 (de) Überwachungsvorrichtungen
NL1028967A1 (nl) 4-Fenylamino-chinazoline-6-yl-amiden.
DK1611884T3 (da) Plaster, indeholdende diclofenac
DK1577222T3 (da) Dåselåg
NO20045464D0 (no) Palleteringssystem
NO20040762D0 (no) Stromskinne.
DE602005001573D1 (de) Gleitfunkenzündkerze mit mehreren Funken
NL1028622A1 (nl) Stelwig.
AT7079U3 (de) Bewässerungsanlage
FR2854914B1 (fr) Echafaudage a structure simplifiee.
FI20045257A0 (fi) Tietoliikennejärjestelmä
FIU20030484U0 (fi) Patukka-ateria
NL1025196A1 (nl) Hark-Zeef-Vork.
FIU20040103U0 (fi) Kastelulaite
ATA10792004A (de) Bewässerungsanlage
FIU20050035U0 (fi) Pikalukitsin
FI20045023A (fi) Pikalukitsin
ITPR20040093A1 (it) Dispositivo per movimentare almeno un oggetto/utensile.
ITSP20040007A1 (it) Il mattone radioattivo.
ITMI20032400A1 (it) Dispositivo scomparsa.
ES1057283Y (es) Conexion para instalaciones de riego.